Illumina Profit Margin

Illumina (ILU.DE) currently reports a profit margin of 18.36% as of June 2026. That compares with 29.37% in the prior-year period — down 37.5% year over year. That is below the Healthcare sector average of 19.13%. Use the charts on this page to explore Illumina's profit margin history and peer comparisons.

Illumina's profit margin decreased from 29.37% to 18.36% — a 37.5% year-over-year decrease (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Illumina's profit margin of 18.36% is lower than the Healthcare sector average of 19.13%. That is roughly 4.0% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Illumina's current 18.36% should be judged against Healthcare norms (sector average: 19.13%) and against ILU.DE's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 18.36%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 19.13%. From there, open related valuation or income-statement pages for Illumina, and consider following ILU.DE for alerts when major investors trade the stock.